A multicenter dosimetry trial to evaluate radiation absorbed dose from holmium-166-DOTMP in patients with multiple myeloma
Phase of Trial: Phase I/II
Latest Information Update: 19 Jan 2009
At a glance
- Drugs Holmium-166-DOTMP (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 19 Jan 2009 Additional lead centres identified as reported by ClinicalTrials.gov, last updated 19-1-2009.
- 19 Jan 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Sep 2005 New trial record.